Soleno Therapeutics Inc (SLNO) Stock Price, Quote & News

Company Profile

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was i...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 213 8444

Fax: 650 213 8383

Website: soleno.life

Address:

100 Marine Parkway, Suite 400, Redwood City, United States

GoldmanSlaps Dec. 5 at 2:41 AM

$SLNO so quiet in here lol

0 · Reply

Iightning Dec. 4 at 10:10 PM

1ightning® Premium Options Alert (Actionable) Ticker: $SLNO Contract: Dec 19 $55C Entry: 2.10 Exit: 2.55 Return: +21.53% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

CrispDry Dec. 4 at 3:34 PM

$SLNO been patiently holding my dip buys

0 · Reply

Iightning Dec. 4 at 5:50 AM

1ightning® Premium Options Alert (Actionable) Ticker: $SLNO Contract: Dec 19 $55C Entry: 1.27 Exit: 2.48 Return: +94.40% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

jacksparo Dec. 3 at 11:22 PM

$CAPR $SLNO $RGC $ARQT I have a full documented history here for every trade I shared with my team.. More to come 📈📈📈! 23 years of trading experience!

3 · Reply

zoneclassman1 Dec. 3 at 11:13 PM

$SLNO $IREN $RGC $CAPR Maybe soon you can add $SLS to this post SOON and I am going to love you forever Jack LOL. You are a Legend here in Stocktwits.

0 · Reply

TravisBking87 Dec. 3 at 5:04 PM

$SLNO $IREN $RGC $CAPR I do remember SLNO RGC. Today, CAPR, you definitely got a historical record!

0 · Reply

jacksparo Dec. 3 at 5:01 PM

$SLNO Two years ago I am sure some remember when I called it for almost 600% Today got another one with $IREN From almost 3 to almost 70 bucks. $RGC Close to 1500% move .. $CAPR Today this one moved massively up! I can count a lot more in my history all saved here in my Stocktwits account ✅! Soon I will be announcing my possible incoming ones in my Christmas 🎄 gift for my team members! 📈📈✅📈📈✅!

0 · Reply

Iightning Dec. 3 at 9:47 AM

1ightning® Premium Options Alert (Actionable) Ticker: $SLNO Contract: Dec 19 $25C Entry: 40.35 Exit: 60.37 Return: +49.62% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Quantumup Dec. 2 at 9:29 PM

Raymond James🏁 $AARD Strong Buy/$47 $SLNO $RYTM $LLY $NVO VKTX Here's what Raymond James said in its initiation report: https://x.com/Quantumup1/status/1995967645267771758?s=20

1 · Reply

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Dec 3, 2025, 7:02 PM EST - 1 day ago

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet?

Dec 3, 2025, 4:05 PM EST - 1 day ago

Soleno Therapeutics Announces the Passing of Board Member William G. Harris

Nov 13, 2025, 12:17 PM EST - 21 days ago

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% – Hagens Berman

Nov 12, 2025, 10:56 AM EST - 22 days ago

Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm

Nov 11, 2025, 7:00 AM EST - 23 days ago

Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement

Nov 7, 2025, 10:04 AM EST - 27 days ago

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman

Nov 5, 2025, 1:46 AM EST - 4 weeks ago

Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:01 PM EST - 4 weeks ago

Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR

Oct 28, 2025, 8:00 AM EDT - 5 weeks ago

Soleno Therapeutics to Participate in Upcoming November Conferences

Oct 11, 2025, 8:45 AM EDT - 7 weeks ago

Soleno: Blockbuster Launch In Progress

Oct 9, 2025, 1:47 PM EDT - 2 months ago

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman

Oct 9, 2025, 12:35 PM EDT - 2 months ago

SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm

Sep 10, 2025, 7:51 PM EDT - 3 months ago

Soleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Sep 10, 2025, 5:23 PM EDT - 3 months ago

SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Sep 10, 2025, 12:57 PM EDT - 3 months ago

Soleno reports death of patient who took genetic disorder treatment, shares fall

Sep 5, 2025, 2:09 AM EDT - 3 months ago

Soleno Therapeutics, Inc. (SLNO) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 4, 2025, 5:05 AM EDT - 3 months ago

Soleno Therapeutics, Inc. (SLNO) Presents At Cantor Global Healthcare Conference 2025 Transcript

Aug 27, 2025, 8:00 AM EDT - 3 months ago

Soleno Therapeutics to Participate in Upcoming September Conferences

Aug 15, 2025, 1:30 PM EDT - 3 months ago

Soleno Under Serious Scrutiny As Short Seller Alleges PWS Drug Is Overpriced, Unsafe

Aug 7, 2025, 3:01 AM EDT - 4 months ago

Soleno Therapeutics, Inc. (SLNO) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 8:21 PM EDT - 4 months ago

Soleno (SLNO) Q2 Revenue Jumps 30%

Aug 6, 2025, 4:01 PM EDT - 4 months ago

Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports Second Quarter 2025 Financial Results

Jul 10, 2025, 9:07 AM EDT - 5 months ago

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock

Jul 10, 2025, 6:01 AM EDT - 5 months ago

Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock

Jul 10, 2025, 6:00 AM EDT - 5 months ago

Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025

Jun 20, 2025, 8:00 AM EDT - 5 months ago

Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference

May 22, 2025, 5:32 PM EDT - 7 months ago

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

May 20, 2025, 4:05 PM EDT - 7 months ago

Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with Prader-Willi Syndrome

May 7, 2025, 10:30 PM EDT - 7 months ago

Soleno Therapeutics, Inc. (SLNO) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:01 PM EDT - 7 months ago

Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial Results

Apr 23, 2025, 7:00 AM EDT - 8 months ago

Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET

Apr 14, 2025, 7:00 AM EDT - 8 months ago

Soleno Therapeutics Announces VYKAT(TM) XR Launch

Mar 27, 2025, 8:11 AM EDT - 9 months ago

Soleno Therapeutics Secures FDA Approval For Its First Commercial Drug For Rare Genetic Disorder

Mar 26, 2025, 5:15 PM EDT - 9 months ago

Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome

Jan 29, 2025, 4:05 PM EST - 11 months ago

Soleno Therapeutics to Participate in Upcoming February Investor Conferences

Dec 17, 2024, 4:05 PM EST - 1 year ago

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

Nov 27, 2024, 8:00 AM EST - 1 year ago

Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 8:30 AM EST - 1 year ago

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

Nov 14, 2024, 4:05 PM EST - 1 year ago

Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024

Oct 10, 2024, 2:53 PM EDT - 1 year ago

Soleno Therapeutics Nears FDA Decision: Strong Buy Targeting PWS Hyperphagia Treatments

Oct 8, 2024, 6:51 PM EDT - 1 year ago

SLNO Stock Rises as Prader-Willi Treatment Nears FDA Approval

Oct 8, 2024, 6:29 PM EDT - 1 year ago

Why Soleno Therapeutics Stock Blasted 9% Higher Today

GoldmanSlaps Dec. 5 at 2:41 AM

$SLNO so quiet in here lol

0 · Reply

Iightning Dec. 4 at 10:10 PM

1ightning® Premium Options Alert (Actionable) Ticker: $SLNO Contract: Dec 19 $55C Entry: 2.10 Exit: 2.55 Return: +21.53% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

CrispDry Dec. 4 at 3:34 PM

$SLNO been patiently holding my dip buys

0 · Reply

Iightning Dec. 4 at 5:50 AM

1ightning® Premium Options Alert (Actionable) Ticker: $SLNO Contract: Dec 19 $55C Entry: 1.27 Exit: 2.48 Return: +94.40% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

jacksparo Dec. 3 at 11:22 PM

$CAPR $SLNO $RGC $ARQT I have a full documented history here for every trade I shared with my team.. More to come 📈📈📈! 23 years of trading experience!

3 · Reply

zoneclassman1 Dec. 3 at 11:13 PM

$SLNO $IREN $RGC $CAPR Maybe soon you can add $SLS to this post SOON and I am going to love you forever Jack LOL. You are a Legend here in Stocktwits.

0 · Reply

TravisBking87 Dec. 3 at 5:04 PM

$SLNO $IREN $RGC $CAPR I do remember SLNO RGC. Today, CAPR, you definitely got a historical record!

0 · Reply

jacksparo Dec. 3 at 5:01 PM

0 · Reply

Iightning Dec. 3 at 9:47 AM

1ightning® Premium Options Alert (Actionable) Ticker: $SLNO Contract: Dec 19 $25C Entry: 40.35 Exit: 60.37 Return: +49.62% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Quantumup Dec. 2 at 9:29 PM

Raymond James🏁 $AARD Strong Buy/$47 $SLNO $RYTM $LLY $NVO VKTX Here's what Raymond James said in its initiation report: https://x.com/Quantumup1/status/1995967645267771758?s=20

1 · Reply

Iightning Dec. 2 at 12:05 AM

**1ightning® Premium Options Alert (Actionable)** **Ticker:** $SLNO **Contract:** Dec 19 $50C **Entry:** 3.46 **Exit:** 5.95 **Return:** **+71.78% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**

0 · Reply

smartkarma Nov. 28 at 3:29 AM

$SLNO | Primer: Soleno Therapeutics (SLNO US) - Nov 2025 "Soleno Therapeutics has achieved a major milestone with the recent FDA approval of its lead drug, VYKAT™ XR (diazoxide choline extended-release..." - αSK (Smartkarma) Read more: https://www.smartkarma.com/insights/primer-soleno-therapeutics-slno-us-nov-2025

0 · Reply

Iightning Nov. 26 at 2:56 AM

1ightning® Options Trade Alert (Actionable) | Buy $SLNO Dec 19 $50 Call | Enter: $1.66 Exit: $2.45 | Profit: 47.19% ROI | https://1ightning.com

0 · Reply

Jrmartin2 Nov. 26 at 2:11 AM

$SLNO does this company have a good pipeline? I can’t find anything on their website

1 · Reply

CH_Expat Nov. 25 at 10:04 PM

$SLNO @DLAT94 Great start! Geht sich aus!

2 · Reply

Tdorsey1776 Nov. 25 at 4:49 PM

$TMDX $SLNO Looks like the Scorpion short positions are getting roasted. Wrong time to heavily short bios.

0 · Reply

Iightning Nov. 25 at 1:01 PM

1ightning® Options Trade Alert (Actionable) | Buy $SLNO Dec 19 $50 Call | Enter: $1.66 Exit: $2.45 | Profit: 47.19% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 1:56 AM

1ightning® Options Trade Alert (Actionable) | Buy $SLNO Dec 19 $50 Call | Enter: $1.66 Exit: $2.45 | Profit: 47.19% ROI | https://1ightning.com

0 · Reply

HamBoneXoXo Nov. 23 at 2:04 AM

$SLNO Read the scorpion citizen petition to fda. Some very harsh claims. Not sure what to make of it. Obviously a hit job by a low life but he signed his name on the claim. Did company sue scorpion if their claims are baseless?

1 · Reply

merlin8121 Nov. 22 at 6:43 AM

$SLNO https://www.youtube.com/shorts/_DSnrdOwvBg

1 · Reply

Iightning Nov. 21 at 11:12 PM

1ightning® Options Trade Alert (Actionable) | Buy $SLNO Dec 19 $50 Call | Enter: $3.50 Exit: $6.38 | Profit: 82.15% ROI | https://1ightning.com

0 · Reply

Night_Owl_Biotech Nov. 21 at 8:01 PM

Analysts forecast $SNDX to generate, more or less, the same revenue dollars over the next years as the commercial-stage non-oncology focused bios on the attachment yet SNDX trades at the lowest market cap. The non-oncology bios on the attachment had their 1st product approved by the FDA within the last few years like SNDX. The raw data is provided to verify for yourself. SNDX generated 96% gross profit margins on their year to date sales. Hence the valuation disconnect is not due to less profitable COGS profiles. This is not investment advice nor to take away from SNDX's peers trading at market multiples. Our investment club owns TARS. The purpose of this post is only to highlight the SNDX risk v reward profile versus non-oncology peers. NOTE: Market caps are intra-day 11/21/25 $SLNO $TARS $LQDA $ARQT

2 · Reply

Market Cap	2.58B
Revenue (ttm)	0.00
Net Income (ttm)	-175.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	1,161.40
Profit Margin	0.00%
Debt to Equity Ratio	0.10

Volume	1,112,200
Avg Vol	1,863,824
Day's Range	N/A - N/A
Shares Out	53.71M
Stochastic %K	95%
Beta	-3.15
Analysts	Strong Sell
Price Target	$113.83